Disease management
The company has received backing from the state government of Western Australia.
Happify Health chief strategy officer Chris Wasden discusses the company's partnership strategy, the business environment for digital therapeutics and how to encourage physician uptake.
Fujifilm Thailand supports this implementation using Microsoft Azure.
Also, I-MED will expand its deployment of 4DMedical's lung imaging tool across its network in Australia.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.
Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream.
The collaboration comes weeks after Happify announced a partnership with insurer Anthem on a women's health product.
Both RetiKid and RetiAge use AI deep learning algorithms to screen for health conditions in retinal images.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
It will use the funds to deepen its presence across Asia.